You are viewing the site in preview mode

Skip to main content

Peer Review reports

From: Immune modulation in solid tumors: a phase 1b study of RO6870810 (BET inhibitor) and atezolizumab (PD-L1 inhibitor)

Original Submission
22 Jul 2024 Submitted Original manuscript
28 Jul 2024 Author responded Author comments - Daniel Marbach
30 Jul 2024 Author responded Author comments - Daniel Marbach
Resubmission - Version 2
28 Jul 2024 Submitted Manuscript version 2
9 Sep 2024 Reviewed Reviewer Report
27 Sep 2024 Reviewed Reviewer Report
5 Dec 2024 Reviewed Reviewer Report
6 Dec 2024 Reviewed Reviewer Report
29 Jan 2025 Author responded Author comments - Daniel Marbach
Resubmission - Version 3
29 Jan 2025 Submitted Manuscript version 3
30 Jan 2025 Author responded Author comments - Daniel Marbach
Resubmission - Version 4
30 Jan 2025 Submitted Manuscript version 4
7 Feb 2025 Reviewed Reviewer Report
20 Feb 2025 Reviewed Reviewer Report
20 Feb 2025 Reviewed Reviewer Report
24 Feb 2025 Reviewed Reviewer Report
2 Mar 2025 Author responded Author comments - Daniel Marbach
Resubmission - Version 5
2 Mar 2025 Submitted Manuscript version 5
Publishing
3 Mar 2025 Editorially accepted
18 Mar 2025 Article published 10.1186/s12885-025-13851-4

You can find further information about peer review here.

Back to article page